Aurinia Pharmaceuticals (AUPH) Inventory (2020 - 2026)

Aurinia Pharmaceuticals' Inventory history runs 7 years deep, the most recent figure standing at $46.4 million for Q1 2026.

• Quarterly Inventory changed 0.47% year-over-year to $46.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.4 million (changed 0.47% YoY) and the FY2025 annual result came in at $45.7 million, up 16.47% from the prior year.
• Inventory was $46.4 million for Q1 2026 at Aurinia Pharmaceuticals, up from $45.7 million in the prior quarter.
• Across five years, Inventory topped out at $46.5 million in Q2 2025 and bottomed at $24.8 million in Q4 2022.
• A 5-year average of $36.8 million and a median of $38.9 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory surged 64.82% — and 2024, when it declined 1.2%.
• Aurinia Pharmaceuticals' Inventory stood at $24.8 million in 2022, then surged by 60.41% to $39.7 million in 2023, then declined by 1.2% to $39.2 million in 2024, then gained by 16.47% to $45.7 million in 2025, then rose by 1.58% to $46.4 million in 2026.
• Business Quant data shows AUPH's Inventory at $46.4 million in Q1 2026, $45.7 million in Q4 2025, and $44.8 million in Q3 2025.